INCRETINS

作品数：9被引量：20H指数：3
导出分析报告
相关领域：医药卫生更多>>
相关期刊：《World Journal of Diabetes》《World Journal of Hepatology》《Journal of Animal Science and Biotechnology》《China Medical Abstracts(Internal Medicine)》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-9
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease:Opportunities and challenges
《World Journal of Hepatology》2024年第5期731-750,共20页Chencheng Xie Naim Alkhouri Mohamed A Elfeki 
Metabolic dysfunction-associated steatotic liver disease(MASLD)has become the most common chronic liver disease worldwide,paralleling the rising pandemic of obesity and type 2 diabetes.Due to the growing global health...
关键词：Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatohepatitis Glucagon-like peptide-1 Glucose-dependent inulinotropic polypeptide GLUCAGON INCRETIN Receptor agonist 
Hypothesis that alpha-amylase evokes regulatory mechanisms originating in the pancreas,gut and circulation,which govern glucose/insulin homeostasis
《World Journal of Diabetes》2023年第9期1341-1348,共8页Stefan G Pierzynowski Christine Stier Kateryna Pierzynowska 
The anti-incretin theory involving the abolishment of diabetes type(DT)II by some of methods used in bariatric surgery,first appeared during the early years of the XXI century and considers the existence of anti-incre...
关键词：PANCREAS ALPHA-AMYLASE Acini-islet-acinar axis HYPERGLYCAEMIA BARIATRICS INSULIN INCRETINS Glucosedependent insulinotropic polypeptide Glucagon-like peptide-1 Exocrine pancreatic insufficiency Pancreatic enzyme therapy Diabetes 
Diabetes and NAFLD:a high-risk cohort with definite therapeutic potential
《Hepatoma Research》2020年第12期1-11,共11页Lucia Brodosi Alessandra Musio Francesca Alessandra Barbanti Dorina Mita Giulio Marchesini Maria Letizia Petroni 
Barbanti FA is supported by a contract financed by Italian Ministry of Health and Italian Regions(NET-2016-02364191).
Despite the fact that non-alcoholic fatty liver disease(NAFLD)and its severe clinical forms[non-alcoholic steatohepatitis(NASH)and NASH-cirrhosis]are highly prevalent in the general population,there are no licensed dr...
关键词：METFORMIN PIOGLITAZONE INCRETINS DPP-4 inhibitors GLP-1 receptor agonists SGLT-2 inhibitors insulin cirrhosis 
Islet cell dysfunction in patients with chronic pancreatitis被引量：5
《World Journal of Diabetes》2020年第7期280-292,共13页Ayan Roy Jayaprakash Sahoo Sadishkumar Kamalanathan Dukhabandhu Naik Pazhanivel Mohan Biju Pottakkat 
Chronic pancreatitis(CP)is characterized by progressive inflammation and fibrosis of the pancreas that eventually leads to pancreatic exocrine and endocrine insufficiency.Diabetes in the background of CP is very diffi...
关键词：Alpha cell BETA-CELL Chronic pancreatitis DIABETES INCRETINS Pancreatic diabetes 
GLP1 and GIP are involved in the action of synbiotics in broiler chickens
《Journal of Animal Science and Biotechnology》2018年第2期451-459,共9页Pawel Antoni Kolodziejski Maciej Sassek Daniela Chalupka Natalia Leciejewska Leszek Nogowski Pawel Mackowiak Damian Jozefiak Katarzyna Stadnicka Maria Siwek Marek Bednarczyk Tomasz Szwaczkowski Ewa Pruszynska-Oszmalek 
supported by the European Union Seventh Framework Programme for research,technological development and demonstration as part of the ECO-FCE project under grant agreement No.311794;partly funded by the Ministry of Science and Higher Education from funds for science in the years 2015–2016 allocated to an international co-financed project(no W171.PR/2015)
Background: In order to discover new strategies to replace antibiotics in the post-antibiotic era in meat-type chicken production, two new synbiotics were tested:(Lactobacillus salivarius IBB3154 plus galactooligosacc...
关键词：GIP GLP-1 INCRETINS In OVO SYNBIOTICS 
Effects of Acarbose on incretins in newly diagnosed type 2 diabetic patients in different carbohydrate tolerance test被引量：3
《China Medical Abstracts(Internal Medicine)》2017年第1期22-,共1页傅晓莹 
Objective To evaluate the effects of Acarbose on incretin level(glucagon-like peptide 1(GLP-1)and gastric inhibitory polypeptide(GIP)of type 2 diabetes mellitus(T2DM)patients after different kinds of glucose load.Meth...
关键词：GIP Effects of Acarbose on incretins in newly diagnosed type 2 diabetic patients in different carbohydrate tolerance test OGTT GLP TYPE 
Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease被引量：5
《World Journal of Diabetes》2015年第11期1186-1197,共12页Ramiro A Sanchez Hugo Sanabria Cecilia de los Santos Agustin J Ramirez 
Hyperglycemia is associated with an increased risk of cardiovascular disease,and the consequences ofintensive therapy may depend on the mechanism of the anti-diabetic agent(s)used to achieve a tight control.In animal ...
关键词：INCRETINS HYPERTENSION CARDIOVASCULAR effects Dipe 
The influence of exendin and GLP-1 on VCAM-1 and ICAM-1 production in endothelium stimulated by TNF-α and glycated albumin
《Health》2012年第12期1570-1577,共8页Krzysztof Siemianowicz Tomasz Francuz Wojciech Garczorz 
A growing body of evidence indicates that incretins may have pleiotropic beneficial effects beyond lowering glucose blood concentration. The effect of GLP-1 and exendin-4 on coronary arteries endothelium in diabetic a...
关键词：INCRETINS ENDOTHELIUM Adhesion MOLECULES 
Are proton pump inhibitors a new antidiabetic drug? A cross sectional study被引量：7
《World Journal of Diabetes》2011年第12期217-220,共4页Diana Boj-Carceller Pilar Bocos-Terraz Miguel Moreno-Vernis Alejandro Sanz-Paris Pablo Trincado-Aznar Ramón Albero-Gamboa 
AIM: To investigate the effect of proton pump inhibitors (PPIs) on glycemic control (HbA1c) in type 2 diabetic patients. METHODS: A crosssectional study of consecutive in-patients admitted to hospital in any departmen...
关键词：PROTON PUMP INHIBITORS Diabetes MELLITUS Drug therapy HYPOGLYCEMIC agents INCRETINS 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部